Glenmark Pharmaceuticals Limited Open Interest & PCR Analysis
₹2,165Updated 5 Jun 2026, 03:30 pm IST
PCR
0.69
Bearish signal
Max Pain
₹2,240
Spot below by ₹75
Total CE OI
3.77M
Call writers
Total PE OI
2.59M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish
Data as of 2026-06-05
Related Analysis
Frequently Asked Questions
What is Glenmark Pharmaceuticals Limited PCR (Put-Call Ratio) today?▾
Glenmark Pharmaceuticals Limited's current PCR is 0.69. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Glenmark Pharmaceuticals Limited's PCR of 0.69 indicates bearish sentiment.
What is Glenmark Pharmaceuticals Limited OI buildup type today?▾
Glenmark Pharmaceuticals Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Glenmark Pharmaceuticals Limited?▾
Glenmark Pharmaceuticals Limited has total CE (call) OI of 3769875 contracts and total PE (put) OI of 2585625 contracts for the nearest expiry. The PCR is 0.69.
How is open interest analysis useful for Glenmark Pharmaceuticals Limited trading?▾
OI analysis for Glenmark Pharmaceuticals Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Glenmark Pharmaceuticals Limited?▾
Glenmark Pharmaceuticals Limited's max pain is ₹2,240 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.